These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 607047)

  • 21. [Cutaneous, cellular immunity in malignant melanoma].
    Kehrer HC
    Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunology and therapy of malignant melanoma (author's transl)].
    Kokoschka EM; Micksche M
    Wien Klin Wochenschr; 1977 Sep; 89(18):612-22. PubMed ID: 906525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blocking of cellular cytotoxicity by serum factors in progressive malignant melanoma].
    Saal JG; Rieber EP; Hadam M; Riethmüller G; Ehinger H; Wilms K; Wilmanns W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1217-9. PubMed ID: 611821
    [No Abstract]   [Full Text] [Related]  

  • 24. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
    Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
    Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
    Hellström I; Warner GA; Hellström KE; Sjögren HO
    Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological studies in melanoma patients treated with BCG.
    De Vries JE; Rümke P
    Br J Cancer Suppl; 1973 Aug; 1():97-102. PubMed ID: 4804294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Tumour-specific antigens in melanoma.
    Lewis MG
    Proc Natl Cancer Conf; 1972; 7():77-83. PubMed ID: 4587663
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
    Duchková H; Richter J; Kubíková M
    Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunologic reaction-readiness in malignant melanoma].
    Bickhardt R; Kunze J
    Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
    [No Abstract]   [Full Text] [Related]  

  • 30. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
    Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
    Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
    Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
    Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evidence for tumor immunity in human malignant melanoma].
    Nagel GA
    Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017
    [No Abstract]   [Full Text] [Related]  

  • 34. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth and spontaneous regression of swine melanoma: relationship of in vitro leukocyte reactivity.
    Berkelhammer J; Ensign BM; Hook RR; Hecker CJ; Smith GD; Oxenhandler RW
    J Natl Cancer Inst; 1982 Mar; 68(3):461-8. PubMed ID: 6950174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Testing of cellular immune reactivity in melanoma patients with diphenylcyclopropenone in comparison to dinitrochlorobenzol].
    Mayerhausen W; Remy W
    Hautarzt; 1987 Aug; 38(8):449-52. PubMed ID: 3654215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IgG levels in the sera of melanoma patients (author's transl)].
    Daveau M; Pavie-Fischer J; Rivat L; Rivat C; Ropartz C; Peter HH; Cesarini JP; Kourilsky FM
    Ann Dermatol Venereol; 1977; 104(6-7):458-60. PubMed ID: 921180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
    Thatcher N; Crowther D
    Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current aspects of melanoma research. I. Classification, immunology].
    Wätzig V
    Dermatol Monatsschr; 1977 May; 163(5):353-8. PubMed ID: 301834
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
    de Vries JE; Cornain S; Rumke P
    Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.